News

Scientists at UT Dallas have designed a wearable, flexible biosensor that can reliably detect and quantify glucose from very small amounts of human sweat.

Merger will create a robust diagnostic platform focused on improving accuracy of cancer diagnoses.

Laboratory of the Year Award Winner PCL Alverno to highlight partnership with Beckman Coulter diagnostics as key component of their success at upcoming lab quality confab.

Partnership aims to commercialize biosimilars to Rituxan, Herceptin.

The GMP-compliant lab will support the development of topical and injectable pharmaceutical products for the company's North American markets.

Study also identifies the first biological pathway associated with the risk of developing an eating disorder.

Mouse study identifies a possible therapeutic target for a family of disorders.

Imagine being in an accident that leaves you unable to feel any sensation in your arms and fingers. Now imagine regaining that sensation, a decade later, through a mind-controlled robotic arm that is directly connected to your brain.

Watching millions of neurons in the brain interacting with each other is the ultimate dream of neuroscientists. A new imaging method now makes it possible to observe the activation of large neural circuits, currently up to the size of a small-animal brain, in real time and three dimensions.

Findings confirm mutation-caused problem but also reveal a new therapeutic target.